The Center is in consultations with the Russian government to explore the possibility of obtaining the Russian Sputnik V vaccine early, Parliament was told on Friday. Health Minister Ashwini Choubey informed Lok Sabha that the biotechnology department is in talks with the Russian government for the Covid-19 vaccine in India.
“While the government and industry are doing their best to make a safe and effective vaccine for COVID-19 available as soon as possible, exact timelines are difficult to comment on in light of the various complex pathways involved in vaccine development “said the minister. , detailing the progress that ongoing vaccine trials in India have made.
Read also | 30 Covid-19 vaccine candidates in development, government informs Lok Sabha
About 30 candidates for the COVID-19 vaccine are in various stages of development, the minister said. If advanced clinical trials of the COVID-19 vaccine are successful, an effective vaccine will likely be available by the end of the first quarter of 2021, the minister added.
Read also | A look at the state of the vaccine race
In detailing the measures taken by the government for the timely availability of Covid-19 drugs and vaccination, Choubey reported that the CDSCO approved the manufacture and marketing of three drugs: injectable formulations of Remdesivir, tablets of favipiravir and injection of itolizumab, for restricted emergency use in the country. for the treatment of coronavirus infection.
Meanwhile, Russia’s R-Pharm announced on Friday the approval of coronavir for outpatient treatment of mild to moderate Covid-19 coronavirus infection.
(With contributions from the agency)
.
